
Choosing the Right Biotech Exit Strategy
Sep 24, 2019 - 42:15
Radio and PodcastLive Radio & Podcasts
The drug development process is costly, time consuming and laden with risk—with only 1% of drugs making it from pre-clinical all the way to market, according to Pharma Intelligence . To beat these odds, life sciences lea...